Trial intelligence / Profile preview

Modafinil for ADHD in Children and Adolescents

NCT00214981Phase 3Completed

Sponsor
Cephalon, Inc.
Start
Sep 2003
Primary completion
Sep 2006
Countries
1
01

Overview

A Phase 3 trial of modafinil in attention deficit hyperactivity disorder (ADHD), sponsored by Cephalon, Inc.. Started Sep 2003; status: completed.

02

Drugs

modafinil
03

Conditions

attention deficit hyperactivity disorder (ADHD)

Beyond the preview

Go deeper on NCT00214981.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00214981.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call